Filtered news list test | Guerbet

Filtered news list testing

Lymphatic System: New Horizons in Visualization and Treatment

Read the article

Breast imaging using MRI or Contrast-Enhanced Mammography: Friends or Foes? | ECR 22 on-demand symposium

Read the article

Contrast-Enhanced Mammography - Clinical implementation and standardized reporting | ECR 22 on-demand workshop

Read the article

SAGE - A review of real-life safety data in international pharmacovigilance databases| ECR 22 on-demand workshop

Read the article

Helpful Hints to Optimise Your MRI Examination | ECR 22 on-demand workshop

Read the article

MRI Contrast Agents: when non-clinical research meets the actual or future clinical practice | ECR 22 on-demand workshop

Read the article

State of the Art MR Contrast Media in 2022 | ECR 22 on-demand workshop

Read the article

Multiple Sclerosis, Dementia: How can MRI and AI be part of the clinical role in the patient care path? | ECR 22 on-demand workshop

Read the article

AI for prostate cancer imaging: on the cutting-edge | ECR 22 on-demand symposium

Read the article

15
16
17
18
Current page19
20
21
22
23

Single report testing

.pdf

test report fabien V 09-07

Separator

Filtered images

MRI Scanner With Optistar Elite Injector

MRI Scanner With Optistar Elite Injector

Manual news 1

subtitle

item 1 text

item 1 title

Manual news 2

item 1 text

item 1 title

item 2 title

Discover the latest news of Guerbet

Latest news

U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT

Read the press release

2024 revenue

Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow^®, innovative solution dedicated to oncology imaging

Read the press release